-
Something wrong with this record ?
Improved beta-amyloid PET reproducibility using two-phase acquisition and grey matter delineation
O. Belohlavek, M. Jaruskova, M. Skopalova, G. Szarazova, K. Simonova,
Language English Country Germany
Document type Journal Article
NLK
ProQuest Central
from 2002 to 1 year ago
Medline Complete (EBSCOhost)
from 2002-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 2002 to 1 year ago
Health & Medicine (ProQuest)
from 2002 to 1 year ago
- MeSH
- Amyloid beta-Peptides metabolism MeSH
- Adult MeSH
- Cognitive Dysfunction diagnostic imaging metabolism MeSH
- Middle Aged MeSH
- Humans MeSH
- Positron Emission Tomography Computed Tomography * MeSH
- Image Processing, Computer-Assisted * MeSH
- Gray Matter diagnostic imaging metabolism MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
PURPOSE: We investigated whether the reproducibility of standard visual reporting (STD method) in flutemetamol (FMM) PET can be improved using a newly introduced method that uses grey matter edges derived from the perfusion phase (GM-EDGE method). METHODS: Two-phase FMM PET was performed in 121 patients with mild cognitive impairment. Five nuclear medicine physicians blindly and independently evaluated all late-phase scans, initially employing the STD method and later the GM-EDGE method. A five-point scale was used to express the degree of amyloid positivity, and a binary classification (positive/negative) was used in combination with subjective confidence (five-point scale). Multirater Fleiss' kappa, intraclass correlation coefficient (ICC) and inter-rater reliability (Cohen's kappa) were determined for the STD and GM-EDGE methods. RESULTS: The weighted Cohen's kappa values for the five-point measure of amyloid positivity ranged from 0.63 to 0.73 (median 0.70) for the STD method and from 0.76 to 0.89 (median 0.80) for the GM-EDGE method (ICC 0.84, 95% CI 0.79-0.88, for the STD method; 0.91, 95% CI 0.89-0.94, for the GM-EDGE method). The nonweighted Cohen's kappa value for the binary classification ranged from 0.73 to 0.93 (median 0.82) for the STD method and 0.90 to 0.97 (median 0.93) for the GM-EDGE method (Fleiss' kappa 0.82, 95% CI 0.77-0.88, for the STD method; 0.93, 95% CI 0.87-0.99, for the GM-EDGE method). The GM-EDGE method resulted in significantly greater subjective confidence in the readings of four physicians (p < 0.010). The binary classification was concordant among all five physicians in 80.8% of the scans using the STD method and in 91.6% of the scans using the GM-EDGE method (p = 0.016). CONCLUSION: The newly introduced GM-EDGE method was associated with significantly higher inter-rater agreement among physicians and higher subjective confidence in the reading. The method is easy to implement in clinical practice, especially when the perfusion phase is utilized clinically.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028246
- 003
- CZ-PrNML
- 005
- 20190823120942.0
- 007
- ta
- 008
- 190813s2019 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00259-018-4140-y $2 doi
- 035 __
- $a (PubMed)30159586
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Belohlavek, Otakar $u Department of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic. otakar.belohlavek@homolka.cz.
- 245 10
- $a Improved beta-amyloid PET reproducibility using two-phase acquisition and grey matter delineation / $c O. Belohlavek, M. Jaruskova, M. Skopalova, G. Szarazova, K. Simonova,
- 520 9_
- $a PURPOSE: We investigated whether the reproducibility of standard visual reporting (STD method) in flutemetamol (FMM) PET can be improved using a newly introduced method that uses grey matter edges derived from the perfusion phase (GM-EDGE method). METHODS: Two-phase FMM PET was performed in 121 patients with mild cognitive impairment. Five nuclear medicine physicians blindly and independently evaluated all late-phase scans, initially employing the STD method and later the GM-EDGE method. A five-point scale was used to express the degree of amyloid positivity, and a binary classification (positive/negative) was used in combination with subjective confidence (five-point scale). Multirater Fleiss' kappa, intraclass correlation coefficient (ICC) and inter-rater reliability (Cohen's kappa) were determined for the STD and GM-EDGE methods. RESULTS: The weighted Cohen's kappa values for the five-point measure of amyloid positivity ranged from 0.63 to 0.73 (median 0.70) for the STD method and from 0.76 to 0.89 (median 0.80) for the GM-EDGE method (ICC 0.84, 95% CI 0.79-0.88, for the STD method; 0.91, 95% CI 0.89-0.94, for the GM-EDGE method). The nonweighted Cohen's kappa value for the binary classification ranged from 0.73 to 0.93 (median 0.82) for the STD method and 0.90 to 0.97 (median 0.93) for the GM-EDGE method (Fleiss' kappa 0.82, 95% CI 0.77-0.88, for the STD method; 0.93, 95% CI 0.87-0.99, for the GM-EDGE method). The GM-EDGE method resulted in significantly greater subjective confidence in the readings of four physicians (p < 0.010). The binary classification was concordant among all five physicians in 80.8% of the scans using the STD method and in 91.6% of the scans using the GM-EDGE method (p = 0.016). CONCLUSION: The newly introduced GM-EDGE method was associated with significantly higher inter-rater agreement among physicians and higher subjective confidence in the reading. The method is easy to implement in clinical practice, especially when the perfusion phase is utilized clinically.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 _2
- $a kognitivní dysfunkce $x diagnostické zobrazování $x metabolismus $7 D060825
- 650 _2
- $a šedá hmota $x diagnostické zobrazování $x metabolismus $7 D066128
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a počítačové zpracování obrazu $7 D007091
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a PET/CT $7 D000072078
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jaruskova, Monika $u Department of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic.
- 700 1_
- $a Skopalova, Magdalena $u Department of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic.
- 700 1_
- $a Szarazova, Gabriela $u Department of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic.
- 700 1_
- $a Simonova, Katerina $u Department of Nuclear Medicine - PET Centre, Na Homolce Hospital, Roentgenova 37/2, 150 30, Prague 5, Czech Republic.
- 773 0_
- $w MED00007222 $t European journal of nuclear medicine and molecular imaging $x 1619-7089 $g Roč. 46, č. 2 (2019), s. 297-303
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30159586 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190823121156 $b ABA008
- 999 __
- $a ok $b bmc $g 1433395 $s 1066706
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 46 $c 2 $d 297-303 $e 20180829 $i 1619-7089 $m European journal of nuclear medicine and molecular imaging $n Eur J Nucl Med Mol Imaging $x MED00007222
- LZP __
- $a Pubmed-20190813